Teachers Retirement System of The State of Kentucky lifted its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 206.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 167,141 shares of the medical technology company’s stock after acquiring an additional 112,561 shares during the period. Teachers Retirement System of The State of Kentucky owned approximately 0.25% of Hill-Rom worth $18,349,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. BDO Wealth Advisors LLC acquired a new stake in shares of Hill-Rom in the first quarter worth $29,000. CSat Investment Advisory L.P. grew its holdings in Hill-Rom by 78.6% during the 2nd quarter. CSat Investment Advisory L.P. now owns 343 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 151 shares in the last quarter. CWM Advisors LLC acquired a new stake in Hill-Rom during the 1st quarter valued at $39,000. Harvest Fund Management Co. Ltd grew its holdings in Hill-Rom by 141.2% during the 1st quarter. Harvest Fund Management Co. Ltd now owns 820 shares of the medical technology company’s stock valued at $82,000 after purchasing an additional 480 shares in the last quarter. Finally, Cerebellum GP LLC acquired a new stake in Hill-Rom during the 2nd quarter valued at $79,000. 86.29% of the stock is owned by institutional investors.
A number of equities research analysts recently weighed in on HRC shares. Raymond James reaffirmed a “buy” rating on shares of Hill-Rom in a report on Wednesday. Needham & Company LLC decreased their price objective on shares of Hill-Rom from $131.00 to $129.00 and set a “buy” rating for the company in a report on Friday, July 31st. ValuEngine lowered shares of Hill-Rom from a “hold” rating to a “sell” rating in a report on Monday, August 3rd. Morgan Stanley decreased their price objective on shares of Hill-Rom from $123.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, August 3rd. Finally, Robert W. Baird assumed coverage on shares of Hill-Rom in a research report on Tuesday, September 1st. They issued an “outperform” rating and a $115.00 price target on the stock. One analyst has rated the stock with a sell rating and seven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $122.71.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, July 31st. The medical technology company reported $1.95 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.46 by $0.49. The company had revenue of $767.50 million for the quarter, compared to analysts’ expectations of $749.39 million. Hill-Rom had a net margin of 7.05% and a return on equity of 25.48%. The business’s revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.23 EPS. As a group, equities analysts anticipate that Hill-Rom Holdings, Inc. will post 5.45 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, September 18th will be paid a $0.22 dividend. The ex-dividend date is Thursday, September 17th. This represents a $0.88 annualized dividend and a dividend yield of 1.04%. Hill-Rom’s dividend payout ratio is currently 17.32%.
In other news, SVP Mary Kay Ladone sold 2,278 shares of Hill-Rom stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $110.00, for a total value of $250,580.00. Following the transaction, the senior vice president now owns 8,163 shares of the company’s stock, valued at approximately $897,930. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.65% of the company’s stock.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Story: CAC 40 Index
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.